A strategy for mechanically integrating robust hydrogel-tissue hybrid to promote the anti-calcification and endothelialization of bioprosthetic heart valve
Regenerative Biomaterials · 02.01.2024 · 11
DOI: 10.1093/rb/rbae003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 30.01.2024. Verfasst von Haoshuang Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610065, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Programs, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Bioprosthetic heart valve (BHV) replacement has been the predominant treatment for severe heart valve diseases over decades. Most clinically available BHVs are crosslinked by glutaraldehyde (GLUT), while the high toxicity of residual GLUT could initiate calcification, severe thrombosis, and delayed endothelialization. Here, we construed a mechanically integrating robust hydrogel-tissue hybrid to improve the performance of BHVs. In particular, recombinant humanized collagen type III (rhCOLIII), which was precisely customized with anti-coagulant and pro-endothelialization bioactivity, was first incorporated into the polyvinyl alcohol (PVA)-based hydrogel via hydrogen bond interactions. Then, tannic acid was introduced to enhance the mechanical performance of PVA-based hydrogel and interfacial bonding between the hydrogel layer and bio-derived tissue due to the strong affinity for a wide range of substrates. In vitro and in vivo experimental results confirmed that the GLUT-crosslinked BHVs modified by the robust PVA-based hydrogel embedded rhCOLIII and TA possessed long-term anti-coagulant, accelerated endothelialization, mild inflammatory response and anti-calcification properties. Therefore, our mechanically integrating robust hydrogel-tissue hybrid strategy showed the potential to enhance the service function and prolong the service life of the BHVs after implantation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610065, China.
- Institute of Clinical Pathology, West China Hospital of Sichuan University, Chengdu 610041, China.
- College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, China.
Förderung
- National Key Research and Development Programs
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Wu, H., Chen, N., Zheng, T., Li, L., Hu, M., Qin, Y., Guo, G., Yang, L., & Wang, Y. (2024). A strategy for mechanically integrating robust hydrogel-tissue hybrid to promote the anti-calcification and endothelialization of bioprosthetic heart valve. Regenerative Biomaterials, 11. https://doi.org/10.1093/rb/rbae003
Vancouver
Wu H, Chen N, Zheng T, Li L, Hu M, Qin Y, et al. A strategy for mechanically integrating robust hydrogel-tissue hybrid to promote the anti-calcification and endothelialization of bioprosthetic heart valve. Regenerative Biomaterials. 2024;11. doi:10.1093/rb/rbae003
BibTeX
@article{Wu2024,
author = {Wu, Haoshuang and Chen, Nuoya and Zheng, Tiantian and Li, Li and Hu, Mengyue and Qin, Yumei and Guo, Gaoyang and Yang, Li and Wang, Yunbing},
title = {A strategy for mechanically integrating robust hydrogel-tissue hybrid to promote the anti-calcification and endothelialization of bioprosthetic heart valve},
journal = {Regenerative Biomaterials},
year = {2024},
volume = {11},
doi = {10.1093/rb/rbae003}
}
EUVIMED